Shear Stress-mediated Pregnancy Adaptations of Uterine Artery Endothelial...
剪切应力介导的子宫动脉内皮细胞的妊娠适应...
基本信息
- 批准号:7189523
- 负责人:
- 金额:$ 17.19万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2007
- 资助国家:美国
- 起止时间:2007-05-01 至 2012-04-30
- 项目状态:已结题
- 来源:
- 关键词:AddressAgonistArteriesBirth WeightBlood VesselsBlood flowCell CommunicationCell physiologyCellsConnexin 43CoupledCouplingCultured CellsCytosolic Phospholipase A2DataDiseaseElevationEmployee StrikesEndothelial CellsEndotheliumEstrogen ReceptorsEstrogensFetal GrowthFetal Growth RetardationFunctional disorderGap JunctionsHTATIP geneICI 182780In VitroLinkLuteal PhaseMAP Kinase GeneMAPK Signaling Pathway PathwayMeasuresMediatingMicroscopeMitogen Activated Protein Kinase 1ModelingNeonatalNitric OxidePLA2G4A genePathologicPatient currently pregnantPerfusionPhenotypePhosphorylationPhosphotransferasesPre-EclampsiaPregnancyProductionProgram DevelopmentProteinsReportingResearch PersonnelRoleSheepSignal TransductionSlideStimulusTestingThird Pregnancy TrimesterTimeVascular Endothelial CellVascular Endothelial Growth Factor Receptor-1Vascular Endothelial Growth Factor Receptor-2Vascular Endothelial Growth FactorsVasodilationVasodilation disorderVasodilator Agentsangiogenesisbasecyclooxygenase 1fetalhuman PLA2G4A proteinhuman embryonic stem cellin vivoneovascularizationnovelprogramsreceptorresponseshear stress
项目摘要
Pregnancy is associated with dramatic increases in uterine blood flows correlating with fetal growth and survival.
The uteroplacental unit has prominent production of estrogen, NO and eNOS expression. Estrogen increases NO
production. Uterine Artery Endothelial Cells (UAEC) of Pregnancy (P) show specific "Programmed Adaptation"
[not seen in Nonpregnant (NP)-UAEC] that maintains in cell culture passages. "Programmed Adaptation" thus is a
UAEC response of freshly isolated UA Endothelium ex vivo, that upon many passages does not diminish. The
overall hypothesis of this proposal is that: In pregnancy, shear stress/flow in the presence of estrogen
causes "Programmed Adaptation" of the UAEC to modulate important endothelial functions associated
with NO-mediated vasodilator production. We will give specific emphasis to those mechanisms that
increase eNOS activation, eNOS expression, UAEC signaling kinases (e.g. ERK 1/2),and cell-cell
communication (measured as synchronized Ca2+ bursts) as modulated by VEGF and Gapjunctions.
Aim 1: Effects of prolonged Laminar Shear Stress with and without E2(3on expression of key functional
proteins (eNOS, COX-1, PGIS, cPLA2, CX43, ERa, ERp, VEGFR-1, VEGFR-2, and NP-1) necessary for
adaptation in UAECs from Luteal Phase Nonpregnant Sheep (NP-UAEC) and Late Pregnant Sheep (P-
UAEC).
Aim 2: Effects of prolonged Laminar Shear Stress with and without E2pon "Programmed Adaptation" in
UAECs from NP-UAEC and P-UAEC. Three "Programmed Adaptation Specific Markers" include: a)ATP/VEGF-
stimulated eNOS activation; b) ATP/VEGF-stimulated ERK1/2 phosphorylation; and c) ERK-MAPK and Gap
junction mediated ATP-induced Ca2+ bursts.
Aim 3: Effects of Estrogen Receptor antagonism with ICI 182,780 on the expression of key functional
proteins (as in Aim 1) necessary for Shear Stress/E2p adaptation of UAECs.
Aim 4: Effects of Estrogen Receptor antagonism with ICI 182,780 on Shear Stress/E2p UAEC
"Programmed Adaptation Specific Markers" (as in Aim 2).
Aim 5: Evaluate the effect of prolonged Laminar Shear Stress on development of programmed endothelial
cell functions comparing responses of endothelial cells derived from human Embryonic Stem Cells
(Project III) to human Embryonic Stem Cells (Project IV; Core B) themselves.
These studies will provide a mechanistic framework for understanding interactions between shear stress and
estrogen to regulate NO production via VEGF and gap junction mediated cell-cell communication. Vascular
adaptations in pregnancy are important because increases in fetoplacental/uteroplacental perfusion, are linked
directly to fetal growth and these mechanisms are dysfunctionalin pathologic pregnancies (e.g. preeclampsia/ IUGR).
妊娠与子宫血流量的急剧增加有关,子宫血流量与胎儿的生长和存活有关。
子宫胎盘单位具有显著的雌激素产生、NO和eNOS表达。雌激素增加NO
生产妊娠期子宫动脉内皮细胞(UAEC)具有特异性的“程序性适应”
[not在非妊娠(NP)-UAEC中观察到],其维持在细胞培养传代中。因此,“程序化适应”是一种
新鲜分离的UA内皮素离体的UAEC反应,在多次传代后不会减少。的
这一建议的总体假设是:在怀孕期间,在雌激素存在下的剪切应力/流动
引起UAEC的“程序性适应”,以调节重要的内皮功能,
一氧化氮介导的血管扩张剂的产生。我们将特别强调那些机制,
增加eNOS活化、eNOS表达、UAEC信号传导激酶(例如ERK 1/2)和细胞-细胞
图2示出了由VEGF和缝隙连接调节的细胞间通讯(测量为同步的Ca 2+爆发)。
目的1:长时间的层流剪切应力(含和不含E2 β)对关键功能蛋白表达的影响
蛋白质(eNOS、考克斯-1、PGIS、cPLA 2、CX 43、ER α、ER β、VEGFR-1、VEGFR-2和NP-1),
来自黄体期非妊娠绵羊(NP-UAEC)和晚孕绵羊(P-UAEC)的UAEC的适应性
UAEC)。
目的2:在有和没有E2的情况下,延长的层流剪切应力对“程序化适应”的影响,
来自NP-UAEC和P-UAEC的UAEC。三种“程序化适应特异性标志物”包括:
刺激的eNOS活化; B)ATP/VEGF刺激的ERK 1/2磷酸化;和c)ERK-MAPK和Gap
连接介导的ATP诱导的Ca 2+爆发。
目的3:用ICI 182,780拮抗雌激素受体对关键功能性细胞因子表达的影响。
UAEC的剪切应力/E2 p适应所必需的蛋白质(如目的1中所述)。
目的4:ICI 182,780对剪切应力/E2 p UAEC的雌激素受体拮抗作用
“程序化适应特定标记”(如目标2)。
目的5:评价长期层流剪切应力对程序性内皮细胞发育的影响。
细胞功能比较人胚胎干细胞来源的内皮细胞的反应
(项目III)到人类胚胎干细胞(项目IV;核心B)本身。
这些研究将为理解剪切应力和剪切力之间的相互作用提供一个机制框架。
雌激素通过VEGF和缝隙连接介导的细胞间通讯调节NO的产生。血管
妊娠期的适应是重要的,因为胎儿胎盘/子宫胎盘灌注的增加,
直接影响胎儿生长,这些机制在病理性妊娠(如先兆子痫/ IUGR)中功能障碍。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
RONALD R MAGNESS其他文献
RONALD R MAGNESS的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('RONALD R MAGNESS', 18)}}的其他基金
Endothelial Function in a Model of IUGR Induced by Uterine Space Restriction
子宫空间限制引起的 IUGR 模型中的内皮功能
- 批准号:
8639270 - 财政年份:2013
- 资助金额:
$ 17.19万 - 项目类别:
Endothelial Function in a Model of IUGR Induced by Uterine Space Restriction
子宫空间限制引起的 IUGR 模型中的内皮功能
- 批准号:
8851181 - 财政年份:2013
- 资助金额:
$ 17.19万 - 项目类别:
Endothelial Function in a Model of IUGR Induced by Uterine Space Restriction
子宫空间限制引起的 IUGR 模型中的内皮功能
- 批准号:
8786597 - 财政年份:2013
- 资助金额:
$ 17.19万 - 项目类别:
Physiologic Cardiovascular & Uterine eNOS Responses:Role of Endogenous Estrogen
生理心血管
- 批准号:
7499532 - 财政年份:2007
- 资助金额:
$ 17.19万 - 项目类别:
Physiologic Cardiovascular & Uterine eNOS Responses:Role of Endogenous Estrogen
生理心血管
- 批准号:
7635379 - 财政年份:2007
- 资助金额:
$ 17.19万 - 项目类别:
Physiologic Cardiovascular & Uterine eNOS Responses:Role of Endogenous Estrogen
生理心血管
- 批准号:
7322457 - 财政年份:2007
- 资助金额:
$ 17.19万 - 项目类别:
Physiologic Cardiovascular & Uterine eNOS Responses:Role of Endogenous Estrogen
生理心血管
- 批准号:
7663772 - 财政年份:2007
- 资助金额:
$ 17.19万 - 项目类别:
Physiologic Cardiovascular & Uterine eNOS Responses:Role of Endogenous Estrogen
生理心血管
- 批准号:
7898863 - 财政年份:2007
- 资助金额:
$ 17.19万 - 项目类别:
相似国自然基金
Agonist-GPR119-Gs复合物的结构生物学研究
- 批准号:32000851
- 批准年份:2020
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
相似海外基金
S1PR1 agonistによる脳血液関門制御を介した脳梗塞の新規治療法開発
S1PR1激动剂调节血脑屏障治疗脑梗塞新方法的开发
- 批准号:
24K12256 - 财政年份:2024
- 资助金额:
$ 17.19万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
AHR agonistによるSLE皮疹の新たな治療薬の開発
使用 AHR 激动剂开发治疗 SLE 皮疹的新疗法
- 批准号:
24K19176 - 财政年份:2024
- 资助金额:
$ 17.19万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Evaluation of a specific LXR/PPAR agonist for treatment of Alzheimer's disease
特定 LXR/PPAR 激动剂治疗阿尔茨海默病的评估
- 批准号:
10578068 - 财政年份:2023
- 资助金额:
$ 17.19万 - 项目类别:
AUGMENTING THE QUALITY AND DURATION OF THE IMMUNE RESPONSE WITH A NOVEL TLR2 AGONIST-ALUMINUM COMBINATION ADJUVANT
使用新型 TLR2 激动剂-铝组合佐剂增强免疫反应的质量和持续时间
- 批准号:
10933287 - 财政年份:2023
- 资助金额:
$ 17.19万 - 项目类别:
Targeting breast cancer microenvironment with small molecule agonist of relaxin receptor
用松弛素受体小分子激动剂靶向乳腺癌微环境
- 批准号:
10650593 - 财政年份:2023
- 资助金额:
$ 17.19万 - 项目类别:
AMPKa agonist in attenuating CPT1A inhibition and alcoholic chronic pancreatitis
AMPKa 激动剂减轻 CPT1A 抑制和酒精性慢性胰腺炎
- 批准号:
10649275 - 财政年份:2023
- 资助金额:
$ 17.19万 - 项目类别:
A randomized double-blind placebo controlled Phase 1 SAD study in male and female healthy volunteers to assess safety, pharmacokinetics, and transient biomarker changes by the ABCA1 agonist CS6253
在男性和女性健康志愿者中进行的一项随机双盲安慰剂对照 1 期 SAD 研究,旨在评估 ABCA1 激动剂 CS6253 的安全性、药代动力学和短暂生物标志物变化
- 批准号:
10734158 - 财政年份:2023
- 资助金额:
$ 17.19万 - 项目类别:
Investigating mechanisms underpinning outcomes in people on opioid agonist treatment for OUD: Disentangling sleep and circadian rhythm influences on craving and emotion regulation
研究阿片类激动剂治疗 OUD 患者结果的机制:解开睡眠和昼夜节律对渴望和情绪调节的影响
- 批准号:
10784209 - 财政年份:2023
- 资助金额:
$ 17.19万 - 项目类别:
A novel nanobody-based agonist-redirected checkpoint (ARC) molecule, aPD1-Fc-OX40L, for cancer immunotherapy
一种基于纳米抗体的新型激动剂重定向检查点 (ARC) 分子 aPD1-Fc-OX40L,用于癌症免疫治疗
- 批准号:
10580259 - 财政年份:2023
- 资助金额:
$ 17.19万 - 项目类别:
Identification and characterization of a plant growth promoter from wild plants: is this a novel plant hormone agonist?
野生植物中植物生长促进剂的鉴定和表征:这是一种新型植物激素激动剂吗?
- 批准号:
23K05057 - 财政年份:2023
- 资助金额:
$ 17.19万 - 项目类别:
Grant-in-Aid for Scientific Research (C)














{{item.name}}会员




